Previous 10 | Next 10 |
home / stock / clzny / clzny news
The following slide deck was published by Clariant AG in conjunction with their 2022 Q3 earnings call. For further details see: Clariant AG 2022 Q3 - Results - Earnings Call Presentation
Clariant AG (CLZNF) Q3 2022 Earnings Conference Call October 27, 2022 09:00 AM ET Company Participants Andreas Schwarzwaelder - Head, Investor Relations Conrad Keijzer - Chief Executive Officer Bill Collins - Chief Financial Officer Conference Call Particip...
Stepan manufactures critical components for key industries. Recent headwinds, which are most likely temporary, have caused a decline of ~18% in the share price, but the PS ratio has suffered even more. The company is successfully increasing the base price of its products as it is ...
Clariant AG (CLZNF) Q2 2022 Earnings Conference Call July 28, 2022 09:00 AM ET Company Participants Andreas Schwarzwaelder - Head, Investor Relations Conrad Keijzer - Chief Executive Officer Bill Collins - Chief Financial Officer Conference Call Participant...
The following slide deck was published by Clariant AG in conjunction with their 2022 Q2 earnings call. For further details see: Clariant AG 2022 Q2 - Results - Earnings Call Presentation
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Cla...
Clariant AG (CLZNF) Q1 2022 Earnings Conference Call June 15, 2022, 09:00 AM ET Company Participants Andreas Schwarzwaelder - Head of IR Conrad Keijzer - CEO Stephan Lynen - Executive VP & CFO Conference Call Participants Christian Faitz - Kepler Cheuvreux Andrew Stott - UBS Georgina Iwam...
The following slide deck was published by Clariant AG in conjunction with their 2022 Q1 earnings call. For further details see: Clariant AG 2022 Q1 - Results - Earnings Call Presentation
NEW YORK, NY / ACCESSWIRE / April 19, 2022 / Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Clariant AG ADR ("Clariant AG" or the "Company") (OTC PINK:CLZNY) . If you suffered losses exceeding $50,000 investing in Clariant AG st...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Clariant AG To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 24, 2022) - Faruqi & Faruqi, LLP, a leading national securities law f...
News, Short Squeeze, Breakout and More Instantly...
Clariant AG ADR Company Name:
CLZNY Stock Symbol:
OTCMKTS Market:
Gevo Inc. (GEVO) is expected to report $-0.05 for Q4 2023 Harvard Bioscience Inc. (HBIO) is expected to report $0.03 for Q4 2023 QuantaSing Group Limited (QSG) is expected to report $0.11 for Q2 2024 DFI Retail Group Holdings Limited ADR (DFIHY) is expected to report for quarter end 2...
Clariant AG ADR (CLZNY) is expected to report for Q4 2023
NEW YORK, June 19, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Carvana Co. (NYSE: CVNA), Enochian Biosciences, Inc. (NASDAQ: ENOB), Corcept Therapeutics, Inc. (NASDAQ: CORT), and Cla...